Health
Will the Pfizer–BioNTech vaccine be effective against the new N501Y SARS-CoV-2 variant? – News-Medical.Net
Researchers from Pfizer and the University of Texas, USA, have presented evidence showing that people in a previously reported trial of the mRNA-based COVID-19…
While the coronavirus disease 2019 (COVID-19) pandemic continues to wreak havoc in many parts of the world, a new variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged.
This new variant, called N501Y, has caused skyrocketing cases in the UK, where it first emerged in September 2020. To date, the country has reported more than 3.12 million cases and over 82,000 deaths.
The rise of this highly infectious new strain has raised serious questions about whether or not…
-
Business22 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News21 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News22 hours agoYoung voices shape Sunshine Coast’s future
-
Noosa News20 hours agoStar Entertainment signs $300m lifeline deal with US gaming giant Bally’s